Stock Price Forecast

Jan. 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Clovis Oncology Inc chart...

About the Company

Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered in Boulder, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline. As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009. In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.

CEO

Patrick Mahaffy

Exchange

NASDAQ

Website

http://clovisoncology.com

$18M

Total Revenue

429

Employees

$9M

Market Capitalization

-0.03

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CLVS News

Clovis Oncology Inc Stock (OTC:CLVSQ), Analyst Ratings, Price Targets, Predictions

1y ago, source: Benzinga.com

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are ...

Why Clovis Oncology (CLVS) Stock is Dropping Today

7y ago, source: TheStreet.com

Clovis Oncology (CLVS) stock is continuing to slide on Monday after the FDA questioned its lung cancer drug Friday. An advisory panel is slated to vote on the drug tomorrow. Clovis Oncology (CLVS ...

Why Clovis Oncology (CLVS) Stock Hit a One-Year Low Today

9y ago, source: TheStreet.com

NEW YORK -- Clovis Oncology continued to plunge to a one-year low of $38.48 on Tuesday with another day of double-digit declines following disappointing data from ASCO 2014 with regard to the ...

Clovis Oncology

2y ago, source: PMLiVE

This page shows the latest Clovis Oncology news and features for those working in and with pharma, biotech and healthcare. Dave Fredrickson, executive vice president, AZ’s oncology business unit. ...

Dreaming big with small molecules

5y ago, source: pharmaphorum

Patrick J. Mahaffy is one of Clovis Oncology’s co-founders and has served as the company’s president and chief executive officer, and a member of the board of directors since the company’s ...

Atlantic American Stock (NASDAQ:AAME), Quotes and News Summary

25d ago, source: Benzinga.com

Gainers BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday. Gainers Clovis Oncology, Inc. (NASDAQ: CLVS) shares climbed 47.7% to ...

Pyxis Oncology Inc PYXS

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Predictive Oncology Inc POAI

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Before Clovis

12y ago, source: PBS

When did humans first arrive in the Americas? For decades, the "Clovis-first" model of initial colonization held sway. It says that the first Americans were the Clovis people—named for an ...

Reply to P.-H. Luo et al

10d ago, source: ascopubs.org

KEYNOTE-826 is one of only several completed studies to prospectively test PD-L1 expression in patients with cervical cancer. The study was not designed or powered to assess outcomes in the population ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...